Tubular secretion in CKD

Journal of the American Society of Nephrology

Volumn 27, Issue 7, 2016, Pages 2148-2155

  Suchy Dicey, Astrid M ^a,b   Laha, Thomas ^a   Hoofnagle, Andrew ^a   Newitt, Rick ^b   Sirich, Tammy L ^c   Meyer, Timothy W ^c   Thummel, Ken E ^a   Yanez, N David ^a   Himmelfarb, Jonathan ^b   Weiss, Noel S ^a   Kestenbaum, Bryan R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BICARBONATE; CINNAMOYLGLYCINE; CREATININE; ELECTROLYTE; GLYCINE DERIVATIVE; HEMOGLOBIN A1C; HIPPURIC ACID; INDICAN; PARA CRESOL; PARA CRESOL SULFATE; PHOSPHATE; PHOSPHORUS; POTASSIUM; UNCLASSIFIED DRUG; UREA; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; BLACK PERSON; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ESTIMATED GLOMERULAR FILTRATION RATE; EXCRETION FRACTION; FEMALE; FOLLOW UP; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EXCRETION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL CLEARANCE; SECRETION RATE; SMOKING; SODIUM EXCRETION; SOLUTE; SYSTOLIC BLOOD PRESSURE; URIC ACID URINE LEVEL; URINARY EXCRETION; URINE SAMPLING; KIDNEY TUBULE; PATHOPHYSIOLOGY; SECRETION (PROCESS);

FEMALE; HUMANS; KIDNEY TUBULES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 85021849341     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/asn.2014121193     Document Type: Article

References (36)

1. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 80: 17–28, 2011
2. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089–2100, 2005
3. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R: Proteinuria and other markers of chronic kidney disease: A position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 42: 617–622, 2003
4. Sirich TL, Aronov PA, Plummer NS, Hostetter TH, Meyer TW: Numerous protein-bound solutes are cleared by the kidney with high efficiency. Kidney Int 84: 585–590, 2013
5. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J, Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Wright J, Appel L, Greene T, Levin A, Djurdjev O, Wheeler DC, Landray MJ, Townend JN, Emberson J, Clark LE, Macleod A, Marks A, Ali T, Fluck N, Prescott G, Smith DH, Weinstein JR, Johnson ES, Thorp ML, Wetzels JF, Blankestijn PJ, van Zuilen AD, Menon V, Sarnak M, Beck G, Kronenberg F, Kollerits B, Froissart M, Stengel B, Metzger M, Remuzzi G, Ruggenenti P, Perna A, Heerspink HJ, Brenner B, de Zeeuw D, Rossing P, Parving HH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79: 1331–1340, 2011
6. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium: Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93–104, 2011
7. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A, Neaton J, Svendsen K, Mann JF, Yusuf S, Teo KK, Gao P, Nelson RG, Knowler WC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 79: 1341–1352, 2011
8. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D: Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 305: 1545–1552, 2011
9. Abboud H, Henrich WL: Clinical practice. Stage IV chronic kidney disease. N Engl J Med 362: 56–65, 2010
10. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278–285, 1985
11. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652–659, 1982
12. Meyer TW, Walther JL, Pagtalunan ME, Martinez AW, Torkamani A, Fong PD, Recht NS, Robertson CR, Hostetter TH: The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Kidney Int 68: 867–877, 2005
13. Amorim LC, Alvarez-Leite EM: Determination of o-cresol by gas chromatography and comparison with hippuric acid levels in urine samples of individuals exposed to toluene. J Toxicol Environ Health 50: 401–407, 1997
14. Meyer TW, Hostetter TH: Uremia. N Engl J Med 357: 1316–1325, 2007
15. Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE: Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 21: 1041–1051, 2010
16. Mulder TP, Rietveld AG, van Amelsvoort JM: Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine. Am J Clin Nutr 81[Suppl]: 256S–260S, 2005
17. Martinez AW, Recht NS, Hostetter TH, Meyer TW: Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol 16: 3430–3436, 2005
18. Deguchi T, Ohtsuki S, Otagiri M, Takanaga H, Asaba H, Mori S, Terasaki T: Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 61: 1760–1768, 2002
19. Patel KP, Luo FJ, Plummer NS, Hostetter TH, Meyer TW: The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 7: 982–988, 2012
20. Grantham JJCA, editor: Renal Handling of Organic Anions and Cations; Metabolism and Excretion of Uric Acid, Philadelphia, WB Saunders, 1986
21. Anzai N, Kanai Y, Endou H: Organic anion transporter family: Current knowledge. J Pharmacol Sci 100: 411–426, 2006
22. Hoskins JA, Holliday SB, Greenway AM: The metabolism of cinnamic acid by healthy and phenylketonuric adults: A kinetic study. Biomed Mass Spectrom 11: 296–300, 1984
23. Tsutsumi Y, Deguchi T, Takano M, Takadate A, Lindup WE, Otagiri M: Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. J Pharmacol Exp Ther 303: 880–887, 2002
24. Phatchawan A, Chutima S, Varanuj C, Anusorn L: Decreased renal organic anion transporter 3 expression in type 1 diabetic rats. Am J Med Sci 347: 221–227, 2014
25. Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B, Naesens M, Vanrenterghem Y, Kuypers D, Evenepoel P, Meijers B: Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Clin J Am Soc Nephrol 8: 1508–1514, 2013
26. Akiyama Y, Kikuchi K, Saigusa D, Suzuki T, Takeuchi Y, Mishima E, Yamamoto Y, Ishida A, Sugawara D, Jinno D, Shima H, Toyohara T, Suzuki C, Souma T, Moriguchi T, Tomioka Y, Ito S, Abe T: Indoxyl sulfate down-regulates SLCO4C1 transporter through up-regulation of GATA3. PLoS One 8: e66518, 2013
27. Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, Terasaki T: Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: Its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 83: 57–66, 2002
28. Lin CJ, Wu V, Wu PC, Wu CJ: Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS One 10: e0132589, 2015
29. Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G: The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: A systematic review. J Am Soc Nephrol 25: 1897–1907, 2014
30. Robinson-Cohen C, Littman AJ, Duncan GE, Roshanravan B, Ikizler TA, Himmelfarb J, Kestenbaum BR: Assessment of physical activity in chronic kidney disease. J Ren Nutr 23: 123–131, 2013
31. Robinson-Cohen C, Littman AJ, Duncan GE, Weiss NS, Sachs MC, Ruzinski J, Kundzins J, Rock D, de Boer IH, Ikizler TA, Himmelfarb J, Kestenbaum BR: Physical activity and change in estimated GFR among persons with CKD. J Am Soc Nephrol 25: 399–406, 2014
32. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
33. Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 32: 65–79, 1962
34. Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: 167–184, 1990
35. Fine J, Gray R: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496–509, 1999
36. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305: 1553–1559, 2011